2009
DOI: 10.1016/j.vaccine.2009.02.083
|View full text |Cite
|
Sign up to set email alerts
|

Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: A potential vaccine candidate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 13 publications
(14 citation statements)
references
References 41 publications
0
13
0
Order By: Relevance
“…The latter behaviour seems to have been directing pv12 and pv38 evolution, highlighting high conservation at both intra- and inter-species level due to the influence of negative selection exerted on s48/45 domains which are important for red blood cell recognition [30]. Although antigens having low genetic diversity are usually not immunogenic [83] nor do they induce protection-inducing responses [84], some limited polymorphism antigens have been shown to be able to induce immunogenicity and protection [85]. Therefore, pv12 and pv38 (or their s48/45 domains) should be evaluated regarding vaccine development because immune responses against 6-Cys family antigens appear to be directed against structural epitopes in s48/45 domains [86-88], blocking such domains should prevent invasion [30,88] and being highly conserved and having a functional constraint, allele-specific immune responses are thus avoided.…”
Section: Resultsmentioning
confidence: 99%
“…The latter behaviour seems to have been directing pv12 and pv38 evolution, highlighting high conservation at both intra- and inter-species level due to the influence of negative selection exerted on s48/45 domains which are important for red blood cell recognition [30]. Although antigens having low genetic diversity are usually not immunogenic [83] nor do they induce protection-inducing responses [84], some limited polymorphism antigens have been shown to be able to induce immunogenicity and protection [85]. Therefore, pv12 and pv38 (or their s48/45 domains) should be evaluated regarding vaccine development because immune responses against 6-Cys family antigens appear to be directed against structural epitopes in s48/45 domains [86-88], blocking such domains should prevent invasion [30,88] and being highly conserved and having a functional constraint, allele-specific immune responses are thus avoided.…”
Section: Resultsmentioning
confidence: 99%
“…Indeed, scientific publications resulting from research conducted by FIDIC indicate that A. nancymaae and A. nigriceps have been used by them. All these publications have been reported to Corpoamazonia [e.g., Cardenas et al, 2005;Curtidor et al, 2007;Daubenberger et al, 2007;Patarroyo et al, 2006;Rojas-Caraballo et al, 2009;Suárez et al, 2011]. Ruiz-Garcia et al [2013] conducted a molecular genetics analysis of mtDNA COII gene sequences reporting genetic evidence of the illegal trade conducted by FIDIC.…”
Section: Discussionmentioning
confidence: 99%
“…Of the 151 high immunogenic P. vivax proteins, only 3 proteins (ETRAMP11.2, Pv34 and SUB1) have been identified as immunogenic proteins in previous studies, 10,11,32,33 and 2 proteins (RAP2 and MSP4) were considered as potential targets of host immunity to vivax malaria. 34,35 Other proteins have not previously been described as immunologically reactive (Tables S1 and S2, ESI †). Forty of the 151 most immunoreactive proteins were considered as biomarkers for serodiagnosis, and 18 were proteins recognized by malaria serum samples with the area under the receiver operating characteristics (ROCs) curve (AUC) more than 0.95 (Table 1) (Fig.…”
Section: Immunomics Profiles Of the P Vivax Blood Stage Protein Micrmentioning
confidence: 99%